[1] Marjot T, Ray DW, Williams FR, et al. Sleep and liver disease: a bidirectional relationship. Lancet Gastroenterol Hepatol, 2021,6(10): 850-863.
[2] 白如雪, 杨志云,杜时雨,等. 慢性肝病患者的健康相关生存质量调查分析. 中日友好医院学报,2014, 28(2):77-80.
[3] H?user W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenterol Hepatol,2004,2(2): 157-163.
[4] Udompap P, Kim D, Kim WR. Current and future burden of chronic nonmalignant liver disease.Clin Gastroenterol Hepatol,2015,13(12):2031-2041.
[5] 郑亚彬.慢性肝病住院患者生存质量的影响因素研究. 广西医学, 2018,40(7):788-791.
[6] 贺远龙,刘斌. 健康相关生命质量. 现代诊断与治疗,2004, 15 (6): 362-363.
[7] Kaplan RM, Hays RD. Health-related quality of life measurement in public health. Annu Rev Public Health,2022,43:355-373.
[8] Chang R, Qian X, Xuan Z, et al. Health related quality of life and its impacts by chronic diseases in urban community population, Shanghai, China in 2015. Psychology, Psychol Health Med,2021,26(8):931-939.
[9] Cortesi PA, Conti S, Scalone L, et al. Health related quality of life in chronic liver diseases.Liver Int,2020,40(11):2630-2642.
[10] Bahall M, Bailey H. The impact of chronic disease and accompanying bio-psycho-social factors on health-related quality of life. J Family Med Prim Care,2022 ,11(8):4694-4704.
[11] 隆莉芝,袁玲.患者报告结局的应用近况及思考[J].中国全科医学,2020,23(32):4120-4127.
[12] 曹阳,余小萍.PRO 量表国内外研究近况.中医杂志,2014,55(8):710-714.
[13] 李春波,何燕玲.健康状况调查问卷SF-36的介绍. 国外医学(精神病学分册),2002(2):116-119.
[14] Rajan M, Lai KC, Tseng CL, et al. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes. Qual Life Res,2013,22(1):53-64.
[15] Sato S, Nishimura K, Tsukino M, et al. Possible Maximal Change in the SF-36 of Outpatients with Chronic Obstructive Pulmonary Disease and Asthma. J Asthma,2004,41(3):355-365.
[16] Younossi ZM, Stepanova M, Noureddin M, et al. Improvements of fibrosis and disease activity are associated with improvement of patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis. Hepatol Commun,2021,5(7):1201-1211.
[17] Janani K, Jain M, Vargese J, et al. Health-related quality of life in liver cirrhosis patients using SF-36 and CLDQ questionnaires. Clin Exp Hepatol,2018,4(4):232-239.
[18] Chawla KS, Talwalkar JA, Keach JC, et al. Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH). BMJ Open Gastroenterol,2016,3(1):e000069.
[19] Tajiri K, Futsukaichi YH, Murayama A, et al. Chronic liver disease questionnaire to manage patients with chronic liver diseases. Hepatol Res,2022,52(8):712-720.
[20] Les I, Doval E, Flavià M,et al. Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol, 2010,22(2):221-227.
[21] Yadav D, Askew RL, Palermo T, et al. Association of chronic pancreatitis pain features with physical, mental, and social health. Clin Gastroenterol Hepatol,2023,21(7):1781-1791.e4.
[22] Stanton E, Kowalske K, Won P, et al. Neuropathic Pain After Burn Injury: A Severe and Common Problem in Recovery. Ann Surg,2023.
[23] Lee SJ, Onstad L, Chow EJ, et al.Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica,2018,103(9):1535-1541.
[24] Desai AP, Madathanapalli A, Tang Q, et al. PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology,2023,78(6):1788-1799.
[25] Younossi ZM, Stepanova M, Henry L.et al. Performance and validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in clinical trials of patients with chronic hepatitis C. Value Health,2016,19(5):544-551.
[26] Younossi ZM, Stepanova M, Younossi I, et al. Validation of chronic liver disease questionnaire for nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol,2019,17(10):2093-2100.e3. |
